Tanjina Kader

Dr Tanjina Kader is a Post-doctoral Fellow at Harvard Medical School and soon to be a group leader at Monash University, Melbourne, Australia. She completed her PhD in Cancer Genetics at the Sir Peter McCallum Cancer Center Department of Oncology, University of Melbourne, in 2019. Dr Kader investigated breast premalignant and preinvasive diseases, such as ADH and DCIS, and developed biomarkers for risk stratification. She led the first spatial Pre-cancer Atlas of High Grade Serous Ovarian Cancer at Harvard. She is very passionate about understanding cancer evolution and progression to improve early detection and preventative approaches for gynecological cancers, such as ovarian and endometrial cancers.